Ho, Jenny C Y <br/><br/>
Reversal of endothelial progenitor cell dysfunction in patients with type 2 diabetes using a conditioned medium of human embryonic stem cell-derived endothelial cells.  [electronic resource] 

 -  Diabetes/metabolism research and reviews  Jul 2012 
 - 462-73 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1520-7560 
<br/><br/><label>Standard No.: </label>10.1002/dmrr.2304  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Blotting, Western<br/>Case-Control Studies<br/>Cell Differentiation<br/>Cells, Cultured<br/>Chemokine CXCL12--genetics<br/>Culture Media, Conditioned--pharmacology<br/>Cytokines--metabolism<br/>Diabetes Mellitus, Type 2--physiopathology<br/>Embryonic Stem Cells--cytology<br/>Endothelial Cells--cytology<br/>Hindlimb--blood supply<br/>Humans<br/>Immunoenzyme Techniques<br/>Ischemia--physiopathology<br/>Male<br/>Mice<br/>Mice, SCID<br/>Middle Aged<br/>Neovascularization, Pathologic--prevention & control<br/>Placenta Growth Factor<br/>Pregnancy Proteins--genetics<br/>RNA, Messenger--genetics<br/>Real-Time Polymerase Chain Reaction<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Stem Cells--cytology<br/>Vascular Endothelial Growth Factor A--genetics